Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Thyro-Tabs (levothyroxine) 150 mcg Recalled for Product Mix-Up

Agency Publication Date: January 14, 2026
Share:
Sign in to monitor this recall

Summary

Alvogen, Inc. is recalling a specific lot of Thyro-Tabs (levothyroxine sodium) 150 mcg tablets after a pharmacy reported finding 88 mcg tablets inside a 150 mcg bottle. This mix-up means patients may inadvertently take a lower dose of their thyroid medication than prescribed. The recall affects 1,000-count bottles distributed nationwide throughout the United States.

Risk

Taking a lower dose of levothyroxine than prescribed can lead to symptoms of hypothyroidism, such as fatigue, weight gain, and cold intolerance, as the body is not receiving the intended amount of thyroid hormone replacement.

What You Should Do

  1. Check your medication bottle for Thyro-Tabs (levothyroxine sodium) 150 mcg with lot number MHA21825 and an expiration date of December 31, 2027.
  2. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  3. Call the FDA Consumer Complaint hotline at 1-888-723-3332 for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Levothyroxine Sodium Tablets, USP, Thyro-Tabs (1000 Tablets)
Variants: 150 mcg, Tablet, Rx only
Lot Numbers:
MHA21825 (Exp December 31, 2027)
NDC:
47781-662-10

Distributed by Alvogen, Inc.; Manufactured by LLOYD, Inc.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 98225
Status: Active
Manufacturer: Alvogen, Inc
Sold By: Pharmacies
Manufactured In: United States
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.